Arterial stiffness reduction on GLP-1 — looking for input

sophie_paris said:

CRP reduction on cardiovascular risk — this is the lab result that excites me most: Baseline hsCRP: 11.0 mg/L (high cardiovascular risk) Month 6…

sophie_paris said:

...we're creating a generation dependent on cardiovascular risk...

I understand the concern, but consider this analogy: are we "creating a generation dependent on" blood pressure medication? Cholesterol medication? Thyroid medication?

Obesity is a chronic disease with biological drivers. Treating it with medication is no different from treating any other chronic condition. The "dependency" framing implies weakness or moral failure — neither of which is accurate.

If ongoing medication is what keeps someone healthy, that's successful treatment, not dependency.

A narrower follow-up, since the general answer is now clear:

How would you tell the difference between that and the alternative explanation?

stefan_berlin said:

sophie_paris said: ...we're creating a generation dependent on cardiovascular risk...

6 month update on cardiovascular risk: down 41 lbs, off blood pressure meds, A1C normalized. Genuinely life-changing.

stefan_berlin said:

sophie_paris said: ...we're creating a generation dependent on cardiovascular risk...

Metabolic syndrome resolution on cardiovascular risk: I went from meeting 3 of 5 diagnostic criteria to meeting ZERO after 11 months of treatment.

The 5 criteria (and my journey):

1. Waist circumference: 50" → 34" ✅ Resolved
2. Triglycerides: 240 → 105 ✅ Resolved
3. HDL: 34 → 52 ✅ Resolved
4. Blood pressure: 140/94 → 118/72 ✅ Resolved
5. Fasting glucose: 120 → 86 ✅ Resolved

Metabolic syndrome reversal is, in my view, the most medically significant outcome of GLP-1 therapy.

stefan_berlin said:

sophie_paris said: ...we're creating a generation dependent on cardiovascular risk...

This answered a question I did not know how to ask.